The 5-HT(1A) receptor agonist BAY x 3702 prevents staurosporine-induced apoptosis

European Journal of Pharmacology

Volumn 355, Issue 1, 1998, Pages 95-101

  Suchanek, Bettina ^a   Struppeck, Heidrun ^a   Fahrig, Thomas ^a  

^a BAYER AG   (Germany)

Author keywords

5 HT(1A) receptor; Apoptosis; BAY x 3702; Staurosporine

Indexed keywords

N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; REPINOTAN; SEROTONIN AGONIST; STAUROSPORINE; UNCLASSIFIED DRUG; BENZOPYRAN DERIVATIVE; DNA FRAGMENT; NEUROPROTECTIVE AGENT; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE; SEROTONIN 1 RECEPTOR; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; THIAZOLE DERIVATIVE;

APOPTOSIS; ARTICLE; BRAIN CORTEX; HIPPOCAMPUS; NERVE CELL CULTURE; NEUROPROTECTION; PRIORITY JOURNAL; ANIMAL; CELL CULTURE; DRUG EFFECT; FEMALE; METABOLISM; NERVE CELL; RAT;

ANIMALS; APOPTOSIS; BENZOPYRANS; CELLS, CULTURED; CEREBRAL CORTEX; DNA FRAGMENTATION; FEMALE; HIPPOCAMPUS; NEURONS; NEUROPROTECTIVE AGENTS; PIPERAZINES; PYRIDINES; RATS; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; STAUROSPORINE; THIAZOLES;

EID: 0031595409     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00469-5     Document Type: Article

References (37)

1. 1A receptor agonists in primary cultures of neurons from chick embryo deprived of serum. Brain Res. 777, 179-186.
2. 1A receptors in the rat hippocampus and cortex. Drug Dev. Res. 26, 275-286.
3. Banerjee, P., Adayev, T., Singh, J.K., 1996. Neuroprotective role of the serotonin 1A receptor. Soc. Neurosci. Abstr. 563.6.
4. Bertrand, R., Solary, E., O'Connor, P., Kohn, K.W., Pommier, Y., 1994. Induction of a common pathway of apoptosis by staurosporine. Exp. Cell Res. 211, 314-321.
5. 1A agonists show neuroprotectant activity in rats and mice. Eur. J. Pharmacol. 183, 1953-1954.
6. Bode-Greuel, K.M., Klisch, J., Horváth, E., 1990. Effects of 5-hydroxytryptamine 1A agonists on hippocampal damage after transient forebrain ischemia in the Mongolian gerbil. Stroke 21, 164-166.
7. Boix, J., Llecha, N., Yuste, V.J., Comella, J.X., 1997. Characterization of the cell death process induced by staurosporine in human neuroblastoma cell lines. Neuropharmacology 36, 811-821.
8. 1A binding in rat brain. A combined in situ hybridization/in vitro receptor autoradiographic study. Brain Res. 561, 51-61.
9. Choi, D.W., Maulucci-Gedde, M., Kriegstein, A.R., 1987. Glutamate neurotoxicity in cortical cell culture. J. Neurosci. 7, 357-368.
10. Colino, A., Halliwell, J.V., 1987. Differential modulation of three separate K-conductances in hippocampal CA1 neurons by serotonin. Nature 328, 73-77.
11. Contreras, P.C., Gray, N.M., Ragan, D.M., Lanthorn, T.H., 1992. BMY-14802 protects against ischemia-induced neuronal damage in the gerbil. Life Sci. 51, 1145-1149.
12. Davies, M.F., Diesz, R.A., Prince, D.A., Peroutka, S.J., 1987. Two distinct effects of 5-hydroxytryptamine on single cortical neurons. Brain Res. 423, 347-352.
13. 1A receptor agonists: recent developments and controversial issues. Pharmacology 121, 1-26.
14. De Vry, J., Dietrich, H., Glaser, T., Heine, H.G., Horváth, E., Jork, R., Maerins, T., Mauler, F., Opitz, W., Scherling, D., Schohe-Loop, R., Schwarz, T., 1997. BAY x 3702. Drugs of the Future 22, 341-349.
15. De Vry, J., Schohe-Loop, R., Heine, H.G., Greuel, J.M., Mauler, F., Schmidt, B., Sommermeyer, H., Glaser, T., 1998. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine 1A receptor agonist. J. Pharmacol. Exp. Ther., in press.
16. Dowson, G., Dowson, S.A., Goswami, R., 1997. Chronic exposure to kappa-opioids enhances the susceptibility of immortalized neurons (F-11 kappa) to apoptosis inducing drugs by a mechanism that may involve ceramide. J. Neurochem. 68, 2363-2370.
17. 1A receptor antagonist, WAY-100635. Eur. J. Pharmacol. 281, 81-88.
18. Fujita-Yamaguchi, Y., Kathuria, S., 1988. Characterization of receptor tyrosine-specific protein kinases by the use of inhibitors. Biochem. Biophys. Res. Commun. 157, 955-962.
19. 1A receptor agonist BAY x 3702 in the rat model of acute subdural hematoma. J. Neurotrauma 14, Abstr. 170.
20. 1A receptor agonist BAY x 3702 in rat model of permanent focal cerebral ischemia and traumatic brain injury. Soc. Neurosci. Abstr. 745.9.
21. Jacobson, M.D., Weil, M., Raff, M.C., 1996. Role of CED3/ICE-family proteases in staurosporine-induced programmed cell death. J. Cell Biol. 133, 1041-1051.
22. Jarvis, W.D., Turner, A.J., Povirk, L.F., Traylor, R.S., Grant, S., 1994. Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C. Cancer Res. 54, 1707-1714.
23. 3H]WAY-100635, a novel 5-HT1A receptor antagonist, to rat brain. J. Neurochem. 64, 2716-2726.
24. Kruman, I., Boland, A., Guo, Q., Bruce, A.J., Mattson, M.P., 1997. Roles of subcellular changes in levels of oxy-radicals and calcium in staurosporine-induced neural cell differentiation and apoptosis. Soc. Neurosci. Abstr. 252.1.
25. Linnik, M.D., Zobrist, R.H., Hatfield, M.D., 1993. Evidence supporting a role for programmed cell death in focal cerebral ischemia in rat. Stroke 24, 2002-2008.
26. MacManus, J.P., Buchan, A.M., Hill, I.E., Rasquinha, I., Preston, E., 1993. Global ischemia can cause DNA fragmentation indicative of apoptosis in rat brain. Neurosci. Lett. 164, 89-92.
27. Nicotera, P., Leist, M., 1997. Energy supply and the shape of death in neurons and lymphoid cells. Cell Death Diff. 4, 435-442.
28. Nixon, R.A., Saito, K.I., Grynspan, F., Griffin, W.R., Katayama, S., Honda, T., Mohan, P.S., Shea, T.B., Beermann, M., 1994. Calpain activated neutral protease (calpain) system in aging and Alzheimer's disease. Ann. N.Y. Acad. Sci. 747, 77-91.
29. PorteraCailliau, C., Price, D.L., Martin, L.J., 1997. Non-NMDA and NMDA receptor-mediated excitotoxic neuronal deaths in adult brain are morphologically distinct: further evidence for an apoptosis-necrosis continuum. J. Comp. Neurol. 378, 88-104.
30. Posmantur, R., McGinnis, K., Nadimpalli, R., Gilbertsen, R.B., Wang, K.K.W., 1997. Characterization of CPP32-like protease activity following apoptotic challenge in SH-SY5Y neuroblastoma cells. J. Neurochem. 68, 2328-2337.
31. 1A receptor agonists in rodent models of focal and global cerebral ischemia. Eur. J. Pharmacol. 203, 213-222.
32. Prehn, J.H.M., Welsch, M., Backhauß, C., Nuglisch, J., Ausmeier, F., Karkoutly, C., Krieglstein, J., 1993. Effects of serotonergic drugs in experimental brain ischemia - evidence for a protective role of serotonin in cerebral-ischemia. Brain Res. 630, 10-20.
33. Rink, A., Fung, K.M., Trojanowski, J.Q., Lee, V.M.-Y., Neugebauer, E., McIntosh, T.K., 1995. Evidence of apoptotic cell death after experimental traumatic brain injury in the rat. Am. J. Pathol. 147, 1575-1583.
34. Singh, J.K., Brett, A.C., Boyers, M.J., Dawson, G., Banerjee, P., 1996. Induction of the serotonin 1A receptor in neuronal cells during prolonged stress and degeneration. J. Neurochem. 66, 2361-2372.
35. Tamaoki, T., 1991. Use and specificity of staurosporine, UCN-01 and calphostin C as protein kinase inhibitors. Meth. Enzymol. 201, 340-347.
36. 2+-binding protein ALG-2 and Alzheimer's disease gene ALG-3. Science 271, 521-525.
37. 2+/calmodulin-dependent protein kinase 2. J. Neurochem. 56, 294-298.